OSR Health reported a gross margin of 33.11% and a net margin of -605.60% for the quarter ended Mar 2026. These financial ratios cover 13 quarters of results from Mar 2023 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||
| Gross Margin (Quarter)Gross Margin (Qtr) | 26.35% | 26.35% | 21.76% | 17.48% | 22.16% | 2.89% | 41.69% | 34.02% | 33.11% | ||||
| EBT Margin (Quarter)EBT Margin (Qtr) | -368.63% | -368.68% | -424.80% | -195.59% | -1,496.55% | -460.16% | -715.23% | -2,040.69% | -809.72% | ||||
| EBIT Margin (Quarter)EBIT Margin (Qtr) | -362.83% | -364.03% | -433.36% | -176.00% | -383.28% | -460.51% | -605.89% | -1,674.81% | -757.59% | ||||
| EBITDA Margin (Quarter)EBITDA Margin (Qtr) | -362.83% | -364.03% | -433.36% | -176.00% | -383.28% | -460.51% | -605.89% | -1,674.81% | -757.59% | ||||
| Operating Margin (Quarter)Operating Margin (Qtr) | -362.83% | -364.03% | -433.36% | -176.00% | -383.28% | -460.51% | -605.89% | -1,674.81% | -757.59% | ||||
| Net Margin (Quarter)Net Margin (Qtr) | -368.63% | -258.27% | -407.84% | -146.36% | -1,496.55% | 29.19% | -338.77% | -1,264.96% | -605.60% | ||||
| FCF Margin (Quarter)FCF Margin (Qtr) | -54.80% | -54.80% | -83.41% | -19.78% | -8.42% | -42.50% | -431.92% | -280.64% | -206.99% | ||||
| Efficiency | |||||||||||||
| Inventory Average (Quarter)Inventory Avg. (Qtr) | 0.83M | 0.47M | 0.19M | 0.19M | 0.23M | ||||||||
| Assets Average (Quarter)Assets Avg. (Qtr) | 36.14M | 71.27M | 71.82M | 54.38M | 36.95M | 28.95M | 20.78M | 98.08M | 174.89M | 179.98M | 181.35M | 174.26M | 171.71M |
| Invested Capital (Quarter)Invested Cap. (Qtr) | 1.80M | 0.25M | 0.63M | 1.86M | 2.32M | 0.20M | |||||||
| Asset Utilization Ratio (Quarter)Asset Util. (Qtr) | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||||||
| Leverage & Solvency | |||||||||||||
| Interest Coverage Ratio (Quarter)Interest Cover (Qtr) | 1.19 | -243.82 | -0.00M | -391.33 | -35.01 | -0.34 | -25.27 | -5.55 | -15.64 | -15.07 | |||
| Debt Ratio (Quarter)Debt Ratio (Qtr) | 0.08 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | ||||||
| Times Interest Earned (Quarter)Times Interest Earned (Qtr) | 1.19 | -243.82 | -0.00M | -391.33 | -35.01 | -0.34 | -25.27 | -5.55 | -15.64 | -15.07 | |||
| Valuation | |||||||||||||
| Enterprise Value (Quarter)Enterprise Value (Qtr) | -70.63M | -0.06M | -0.02M | -0.00M | -0.01M | -0.40M | 54.87M | 53.81M | 49.98M | 47.44M | 21.71M | ||
| Return Ratios | |||||||||||||
| Return on Sales (Quarter)ROS (Qtr) | -0.04% | -0.03% | -0.04% | -0.01% | -0.15% | -0.05% | -0.05% | -0.19% | -0.07% | ||||
| Return on Capital Employed (Quarter)ROCE (Qtr) | 0.29% | 0.90% | 1.22% | 2.48% | -6.26% | -23.03% | -57.35% | -12.35% | -7.02% | -8.12% | -8.15% | -11.67% | -12.41% |
| Return on Invested Capital (Quarter)ROIC (Qtr) | -0.03% | -0.04% | -0.03% | ||||||||||
| Return on Assets (Quarter)ROA (Qtr) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |